TB Alliance seeks clinical trial waiver for Pretomanid drug
Posted by
www.biotecnika.org
Pretomanid, a new oral treatment is a shorter more convenient option
for people with extensively drug resistant (XDR) TB. The dossier for
getting approval for the drug has been filed with the drug regulatory
authorities. India not only records highest number of TB cases but
also bears the maximum burden of XDR TB patients.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/tb-alliance-seeks-clinical-trial-waiver-for-pretomanid-drug/articleshow/71849956.cms
Subscribe to:
Post Comments (Atom)
Post a Comment